Table 4 Cluster-level differences in FA and related metrics after 5 years of medication treatment compared to baseline for the treatable AVH group.
 | Baseline | Five years later | P |
---|---|---|---|
n | n = 67 | n = 67 |  |
Mean FA of clusters with significant group differences in FA | 0.50 ± 0.06 | 0.67 ± 0.04 | <0.001a |
Mean AD of clusters with significant group differences in FA | 0.83 ± 0.04(10−3) | 0.92 ± 0.02(10−3) | <0.001a |
Mean RD of clusters with significant group differences in FA | 0.40 ± 0.01(10−3) | 0.59 ± 0.05(10−3) | <0.001a |
Mean MD of clusters with significant group differences in FA | 0.45 ± 0.02(10−3) | 0.72 ± 0.08(10−3) | <0.001a |